Psilera And Usf Collaborators At Morsani College Of Medicine Receive Additional Funding To Support Preclinical Studies On New Chemical Entities
Round Type
Funding Round
TampaBiotechnologyHealth CareScience And EngineeringDescription
Psilera Inc. ("Psilera"), a biotechnology company specializing in the clinical development of psychedelic-inspired compounds and drug delivery systems for treating mental health disorders, was granted more than $130,000 from the Florida High Tech Corridor's Matching Grants Research Program, effectively doubling the life of a study conducted in collaboration with researchers from the University of South Florida ("USF"). This preclinical study focuses on understanding Psilera's non-hallucinogenic N,N-dimethyltryptamine (DMT) derivatives and their therapeutic potential to treat mood and addiction disorders.
Quick answer
Psilera raised an undisclosed amount in a Funding Round round, dated March 8, 2022. Psilera is based in Tampa, Florida, United States.
- How much did Psilera raise?
- Psilera raised an undisclosed amount in a Funding Round round on March 8, 2022.
- What does Psilera do?
- Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders.
- Where is Psilera based and how big is it?
- Psilera is based in Tampa, Florida, United States. Fundz records about 14 employees.
- Who are the decision-makers at Psilera?
- Fundz holds 1 contact at Psilera, including the Co-Founder and CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Psilera that raised within 45 days of this round, from Fundz verified event records.
- Unlearn raised $50M on April 19, 2022.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Surf Bio raised $16M (Seed) on April 12, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Trait Biosciences Inc. raised $210K (Series A) on April 6, 2022.
- Ray Therapeutics raised $6M on April 5, 2022.
Who to call at Psilera, and when
A new round usually means Psilera is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Psilera raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Psilera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Psilera. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Psilera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Psilera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.